Literature DB >> 17576289

The International Quotidian Dialysis Registry: annual report 2007.

Gihad E Nesrallah1, Rita S Suri, Shannon T Carter, Louise M Moist, Amit X Garg, Christian Awaraji, Robert M Lindsay.   

Abstract

In view of the need to study both intermediate and definitive outcomes associated with daily and extended-hours hemodialysis (HD), our group has undertaken the design and implementation of an international registry to collect data describing the treatments and outcomes of patients treated with these regimens. The International Quotidian Dialysis Registry began recruiting patients in June 2004. There are currently 229 patients enrolled in the registry, up from 199 last year. The projected growth is 2000 patients by 2008. This paper constitutes the third annual report of progress of patient and center recruitment, and includes descriptive data drawn from the 3 primary patient groups currently tracked by the registry: home nocturnal, home short-daily, and in-center short-daily HD. As the cohort grows, patients will be compared with control subjects drawn from their respective national registries, and comparative analyses will follow.

Entities:  

Mesh:

Year:  2007        PMID: 17576289     DOI: 10.1111/j.1542-4758.2007.00179.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  3 in total

Review 1.  Hemodialysis in children with end-stage renal disease.

Authors:  Dominik Müller; Stuart L Goldstein
Journal:  Nat Rev Nephrol       Date:  2011-09-06       Impact factor: 28.314

2.  Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis.

Authors:  Gihad E Nesrallah; Meaghan Cuerden; Joseph H S Wong; Andreas Pierratos
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-22       Impact factor: 8.237

Review 3.  Intensified hemodialysis regimens: neglected treatment options for children and adolescents.

Authors:  Dominik Müller; Miriam Zimmering; Christopher T Chan; Philip A McFarlane; Andreas Pierratos; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2008-03-12       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.